Serum-soluble interleukin-2 receptor levels in Kawasaki disease

Bianca A. Lang, Earl D. Silverman, Ronald M. Laxer, Vera Rose, David L. Nelson, Laurence A. Rubin

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

50 Citas (Scopus)
Idioma originalEnglish
Páginas (desde-hasta)592-596
Número de páginas5
PublicaciónJournal of Pediatrics
Volumen116
N.º4
DOI
EstadoPublished - abr. 1990
Publicado de forma externa

Nota bibliográfica

Funding Information:
Recent studies have suggested that immune activation may contribute to the pathogenesis of Kawasaki disease. Abnormalities of immunoregulation include increased numbers of Supported by a fellowship from the Arthritis Society of Canada (Dr. Lang), associateships of The Arthritis Society of Canada (Drs. Silverman, Laxer, and Rubin), and grants from the Canadian Heart Society, the Arthritis Society of Canada, and Baxter Healthcare Corporation, Hyland Division, Glendale, Calif. Submitted for publication July 17, 1989; accepted Oct. 18, 1989. Reprint requests: Earl D. Silverman, MD, Division of Immunology/Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. 9/22/17488

ASJC Scopus Subject Areas

  • Pediatrics, Perinatology, and Child Health

Citar esto